scholarly journals NFAM1 signaling enhances osteoclast formation and bone resorption activity in Paget's disease of bone

Bone ◽  
2017 ◽  
Vol 101 ◽  
pp. 236-244 ◽  
Author(s):  
Yuvaraj Sambandam ◽  
Kumaran Sundaram ◽  
Takamitsu Saigusa ◽  
Sundaravadivel Balasubramanian ◽  
Sakamuri V. Reddy
1980 ◽  
Vol 58 (2) ◽  
pp. 24P-24P
Author(s):  
D. L. Douglas ◽  
T. Duckworth ◽  
J. A. Kanis ◽  
C. J. Preston ◽  
J. S. Woodhead ◽  
...  

1978 ◽  
Vol 23 (2) ◽  
pp. 161-165 ◽  
Author(s):  
T. J. Martin

Calcitonin is a potent hormonal inhibitor of bone resorption. Its major therapeutic effect is in the treatment of Paget's Disease of bone, in which it has been shown to reduce bone pain, lead to radiological and histological improvement in bone, and to restore abnormal biochemistry towards normal. Some patients are resistant to treatment, and in others resistance may develop during treatment. Although antibodies to pig or to salmon calcitonin develop in almost 50 per cent of treated patients it is only very rarely that resistance may be ascribed to antibodies. There are a number of other clinical states of increased resorption in which the value of calcitonin therapy has yet to be established.


1993 ◽  
Vol 22 (1) ◽  
pp. 1-8 ◽  
Author(s):  
N.A.T. Hamdy ◽  
S.E. Papapoulos ◽  
A. Colwell ◽  
R. Eastell ◽  
R.G.G. Russell

2006 ◽  
Vol 39 (11) ◽  
pp. 20
Author(s):  
Elizabeth Mechcatie ◽  
Lora T. McGlade

2014 ◽  
Author(s):  
Maheva Vallet ◽  
Antonia Sophocleous ◽  
Jon Warner ◽  
Stewart W Morris ◽  
James F Wilson ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document